{"top_spans": [[0, 0], [1, 1], [3, 10], [6, 6], [8, 10], [16, 16], [18, 18], [19, 19], [19, 21], [21, 21], [23, 30], [32, 32], [40, 41], [40, 43], [42, 43], [45, 49], [47, 47], [47, 49], [51, 51], [53, 54], [56, 56], [57, 58], [57, 60], [60, 60], [61, 62], [64, 64], [67, 67], [69, 73], [72, 72]], "predicted_antecedents": [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 11, -1, -1, 14, -1, -1, -1, -1, 4, -1, 1, -1, -1], "document": ["we", "spoke", "to", "the", "president", "of", "astrazeneca", "about", "the", "pharma", "giant", "plans", "to", "get", "back", "to", "growth", "after", "losing", "billions", "in", "sales", "to", "generic", "competition", "uk", "-", "based", "pharma", "giant", "astrazeneca", "has", "lost", "out", "on", "12", "billion", "in", "revenue", "in", "the", "past", "few", "years", "because", "some", "of", "its", "big", "treatments", "went", "generic", "now", "the", "company", "is", "hoping", "new", "approvals", "and", "drugs", "the", "company", "is", "developing", "will", "return", "it", "to", "growth", "president", "astrazeneca", "ruud", "dobber"], "clusters": [[[8, 10], [47, 47], [53, 54], [61, 62], [67, 67]]]}